Status:
TERMINATED
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Menopause
Eligibility:
FEMALE
35-65 years
Phase:
PHASE2
Brief Summary
To determine whether treatment with ESTRATEST® Tablets is superior to treatment with esterified estrogens tablets
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Hysterectomized, menopausal women between the ages of 30 and 65 years of age (inclusive) with symptoms of estrogen and/or androgen deficiency not currently controlled by estrogen therapy as determined by patient report and the Investigator's clinical judgement
Exclusion
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT00141557
Start Date
July 1 2004
End Date
March 1 2008
Last Update
April 11 2008
Active Locations (78)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 66
Huntsville, Alabama, United States
2
Site 57
Mobile, Alabama, United States
3
Site 46
Montgomery, Alabama, United States
4
Site 29
Phoenix, Arizona, United States